Suppressive effects of bisphosphonate on bone resorption induced by murine sarcoma

Nihon University Journal of Medicine

Volumn 41, Issue 3, 1999, Pages 121-133

  Kamioka, Hiroaki ^a   Osaka, Shunzo ^b   Suzuki, Koyu ^b   Ryu, Junnosuke ^b  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

Bisphosphonate; Bone resorption; Murine sarcoma

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CREATININE; PROCOLLAGEN; PYRIDINOLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE CANCER; BONE RADIOGRAPHY; CALCIFICATION; CONTROLLED STUDY; DISEASE MARKER; FEMUR; HISTOPATHOLOGY; MALE; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; SARCOMA; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0032802339     PISSN: 05460352     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Hiraga, T., Nakajima T. and Ozawa, E.: Fine structure of bone metastasis. The Bone 10 53-61 (1991) (in Japanese)
2. Nemoto, R., Uchida, K., Tsutsumi, M., Koiso, K., Satou, S. and Satou, T.: A model of localized osteolysis induced by the MBT-2 tumor in mice and its responsiveness to etidronate disodium. J. Cancer. Res. Clin. Oncol. 113 539-545 (1987)
3. Nemoto, R., Uchida, K., Tsutsumi, M., Koiso, K. and Satou, T.: Bone resorption induced by transplantable bladder tumor (MBT-2) in mice. J. Urol. 139 650-652 (1988)
4. Nemoto, R., Sato, S., Nishijima, Y., Miyakawa, I., Koiso, K. and Harada, M.: Effects of a new bisphosphonate (AHBuBP) on osteolysis induced by human prostate cancer cells in nude mice. J. Urol. 144 770-774 (1990)
5. Nemoto, R., Satou, S., Miyagawa, I. and Koiso, K.: Inhibition by a new bisphosphonate (AHBuBP) of bone resorption induced by the MBT-2 tumor of mice. Cancer 67 643-648 (1991)
6. Akatsu, T. and Nagata, N.: Cytokine and bone metastasis. The Bone 10 81-89 (1996) (in Japanese)
7. Mundy, G.R. and Yoneda, T.: Facilitation and suppression of bone metastasis. Clin. Orthop. 312 34-44 (1995)
8. Paterson, A.H.G., Powels, T.J., Kanis, J.A., McCloskey, E., Hanson, J. and Ashley, S.: Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer. J. Clin. Oncol. 11 59-65 (1993)
9. Thiebaud, D., Jaeger, P., Jacquet, A.F. and Burckhardt, P.: A single day treatment of tumor induced hypercalcemia by intravenous amino-hydroxypropylidene bisphosphonate. J. Bone Miner. Res. 1 555-562 (1986)
10. van Breukelen, F.J.M., Bijvoet, L.M. and van Oosterom, A.T.: Inhibition of osteolytic bone lesions by (3-amino-l-hydroxy-propylidene)-l, 1-bisphosphonate (APD). Lancet 1 803-805 (1979)
11. van Breukelen, F.J.M., Bijvoet, L.M., Frijlink, W.B., Sleeboorn, H.P., Mulder, H. and van Oosterom, A.T.: Efficacy of amino-hydroxypropylidene bisphosphonate in hypercalcemia: Observations on regulation of serum calcium. Calcif. Tissue Int. 34 321-327 (1982)
12. Flanagan, A.M. and Chambers, T.J.: Inhibition of bone resorption by bisphosphonates; Interactions between bisphosphonates, osteoclasts, and bone. Calcif. Tissue Int. 49 407-415 (1991)
13. Sato, K.: Malignant tumors and hypercalcemia. Nippon Naikagakkaishi 84 808-812 (1995) (in Japanese)
14. Yamamoto, I. and Moriya, R.: Treatment of osteolytic bone metastasis with bisphosphonates and calcitonin. The Bone 10 125-133 (1996) (in Japanese)
15. Sasaki, A., Boyce, B.F., Story, B., Wright, K.R., Chapman, M., Boyce, R., Mundy, R. and Yoneda, T.: Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice. Cancer Res. 55 3551-3557 (1995)
16. Carey, D.E., Goldberg, B., Ratzan, S.K., Rubin, K.R. and Rowe, D.W.: Radioimmunoassay for Type I procollagen in growth hormone deficient children before and during treatment with growth hormone. Pediatr. Res. 19 8-11 (1985)
17. Fukunaga, M., Otsuka, N., Ono, S. and Miyake, M.: Measurement of its concentration in blood by carboxyterminal propeptide of type I procollagen (P1CP) assay kit. Kidney Metab. Bone Dis. 6 237-245 (1997) (in Japanese)
18. Nakatsuka, K. and Miki, T.: Osteolytic marker. Bone Metabolic Marker 61-72 (1995) (in Japanese)
19. Parfitt, A.M., Simon, L.S., Villanueva, A.R. and Krane, S.M.: Procollagen type I carboxy-terminal extension peptide in serum as a marker of collagen biosynthesis in bone: Correlation with iliac bone formation rates and comparison with total alkaline phosphatase. J. Bone Miner. Res. 2 427-436 (1987)
20. Robins, S.P., Black, D., Paterson, C.R., Reid, D.M., Duncan, A. and Seibel, M.J.: Evaluation of urinary hydroxypyridinium crosslink measurements as resorption markers in metabolic bone disease. Eur. J. Clin. Invest. 21 310-315 (1991)
21. Walls, J., Bundred, N. and Howell, A.: Hypercalcemia and bone resorption in malignancy. Clin. Orthop. 312 51-63 (1995)
22. Thurliamann, B., Morant, R., Jungi, W.F. and Radziwill, A.: Pamidoronate for pain control in patients with malignant osteolytic bone disease: A prospective dose-effect study. Support Care Cancer 2 61-65 (1994)